Abstracts tagged "Epidemiology"

Abstract Number: 0879 • ACR Convergence 2025
Trajectories and risk factors of interstitial lung disease in limited cutaneous systemic sclerosis from the EUSTAR cohort
Antonio Tonutti¹, Francesca Motta¹, Silvia Bellando Randone², Nicoletta Del Papa³, Elisabetta Zanatta⁴, Marie-Elise Truchetet⁵, Christina Bergmann⁶, Gábor Kumánovics⁷, Monique Hinchcliff⁸, Yasser El Miedany⁹, Britta Maurer¹⁰, Marie Vanthuyne¹¹, Lijun Zhang¹², Nune Manukyan¹³, Carlo Selmi¹⁴ and Maria De Santis¹, ¹Humanitas University, Pieve Emanuele, Italy, ²University of Florence, Florence, Italy, ³ASST Pini CTO, Milano, Milan, Italy, ⁴University of Padua, Padova, Italy, ⁵University of Bordeaux, Bordeaux, France, ⁶Department of Medicine ³ - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, ⁷University of Pecs, Pecs, Hungary, ⁸Yale School of Medicine, Westport, CT, ⁹Egyptian Society for Microcirculation in Rheumatic Diseases, Cairo, Egypt, ¹⁰Department of Rheumatology & Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, ¹¹Université Catholique de Louvain, Bruxelles, Belgium, ¹²The University of Hong Kong-Shenzhen Hospital, Shenzhen, China (People's Republic), ¹³Mikaelyan Institute Of Surgery, Yerevan, Armenia, ¹⁴Humanitas University, Milan, Italy
Background/Purpose: Interstitial lung disease (ILD) is traditionally associated with the diffuse subset of systemic sclerosis (dcSSc) but may be observed in limited SSc (lcSSc), with…
Abstract Number: 0354 • ACR Convergence 2025
Greater Neighborhood Walkability is Associated with Lower Incidence of Hip Fracture in Older, Community-dwelling Women in the United States: The Cardiovascular Health Study
Rachel Elam¹, Petra Buzkova², Howard Fink³, Joshua Barzilay⁴, Eric Roseen⁵, Jane Cauley⁶, John Robbins⁷, Laura Carbone¹, Gina Lovasi⁸ and Kenneth Mukamal⁹, ¹Augusta University, Augusta, GA, ²University of Washingon, Seattle, WA, ³University of Minnesota, Minneapolis, MN, ⁴Kaiser Permanente of Georgia, Atlanta, GA, ⁵Boston University, Boston, MA, ⁶University of Pittsburgh, Pittsburgh, PA, ⁷University of California Davis, Davis, CA, ⁸Drexel University, Philadelphia, PA, ⁹Beth Israel Deaconess Medical Center, Brookline, MA
Background/Purpose: Higher physical activity is linked to reduced fracture risk in older adults, especially for hip fractures. Emerging evidence demonstrates a potential role for the…
Abstract Number: 0147 • ACR Convergence 2025
Rheumatoid Arthritis prevalence estimation in France using care pathways in the National Health Data System: opportunities and limitations – PREST study
cécile gaujoux-viala¹, adeline Ruyssen-Witrand², Laurent arnaud³, clélia Bignon-Favary⁴, Lauren Inchboard⁴ and Bruno Fautrel⁵, ¹Department of Rheumatology - CHU Nîmes, IDESP UM¹³¹⁸  INSERM – Univ. Montpellier, Nîmes, France, Nîmes, France, ²Department of Rheumatology, C.H.U. de Toulouse, CIC ¹⁴³⁶, Inserm, Université Paul Sabatier Toulouse III, Toulouse, France, Toulouse, France, ³Service de rhumatologie, Hôpitaux Universitaires de Strasbourg, INSERM UMR-S ¹¹⁰⁹, Strasbourg, France, Strasbourg, France, ⁴Horiana, Statistiques, Bordeaux, France, Bordeaux, France, ⁵Sorbonne Université - APHP, Department of Rheumatology, Hôpital Pitié-Salpêtrière, Inserm UMRS ¹¹³⁶-⁵, PARIS, France, Paris, France
Background/Purpose: A total of 98.8% of French citizens are registered in the National Health Data System (SNDS), which includes claims data of all reimbursed health-related…
Abstract Number: 2569 • ACR Convergence 2025
Performance of the PREVENT Heart Failure General Population Risk Score in Patients with Rheumatoid Arthritis
Ilana Usiskin¹, Katherine Zhong², Ying Qi³, Lauren rusnak¹, Andrew Cagan¹, Yumeko Kawano¹, Tianrun Cai¹, Daniel Solomon⁴, Jennifer Ho⁵, Brittany Weber⁶ and Katherine Liao¹, ¹Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Short Hills, NJ, ³Brigham and Women’s Hospital, Boston, ⁴Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, ⁵Beth Israel Deaconess Medical Center, Boston, MA, ⁶Brigham and Women's Hospital, DEDHAM, MA
Background/Purpose: Patients with rheumatoid arthritis (RA) are at increased risk of heart failure (HF) compared to the general population, and HF with preserved ejection fraction…
Abstract Number: 2004 • ACR Convergence 2025
Characteristics and Management of Gout Patients Under Rheumatologist Care from Low-Income and Middle-Income Asia-Pacific Countries: Data from the APLAR Gout Registry
Kanon Jatuworapruk¹, Binit Vaidya², ANA MONICA ESTRELLA³, MA. HANNA MONICA SOLLANO³, Ronaldo De Vera⁴, Ida Ayu Ratih Wulansari Manuaba⁵, Rakhma Hellmi⁶, Panchalee Satpanich⁷, Nittayawadee Aeamsaard⁸, MAHABALESHWAR MAMADAPUR⁹, Mustafa Alhayali¹⁰, Chang-Nam Son¹¹, Syahrul Sazliyana Shaharir¹², Galymzhan Togizbayev¹³ and Jose Paulo Lorenzo³, ¹Thammasat University, Pathumthani, Thailand, ²National Center for Rheumatic Diseases, Kathmandu, Nepal, ³Makati Medical Center, Makati, Philippines, ⁴Tricity Medical Center in Pasig City, Pasig, Philippines, ⁵Bali International University, Bali, Indonesia, ⁶Kariadi Hospital Medical Center, Semarang, Indonesia, ⁷Faculty of Medicine Vajira Hospital, bangkok, Thailand, ⁸Saraburi Hospital, Saraburi, Thailand, ⁹JSS MEDICAL COLLEGE AND HOSPITAL, Mysore, Karnataka, India, ¹⁰Baghdad Teaching Hospital, Baghdad, Iraq, ¹¹UIJEONGBU EULJI MEDICAL CENTER, EULJI UNIVERSITY, UIJEONGBU, Republic of Korea, ¹²Universiti Kebangsaan Malaysia, Selangor, Malaysia, ¹³Qazaq College of Rheumatology, Almaty, Kazakhstan
Background/Purpose: The burden of gout is rising in low-income and middle-income countries in the Asia-Pacific region. However, individuals with gout in this region remain underrepresented…
Abstract Number: 1893 • ACR Convergence 2025
Increased Atrial Fibrillation Risk in Rheumatoid Arthritis: Greater in Seropositive Than Seronegative Patients
Hyungjin Kim¹, Seonyoung Kang², Kyungdo Han³, Jinhyung Jung⁴, Seulkee Lee⁵, Hoon-Suk Cha⁵, Jaejoon Lee⁶, Seonghye Kim⁵ and Se Yun Kim⁷, ¹Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, ²Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea, ³Soongsil University, Seoul, Republic of Korea, ⁴Sungkyunkwan University School of Medicine, Suwon, Republic of Korea, ⁵Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, ⁶Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, ⁷Sungkyunkwan University, Seoul, Republic of Korea
Background/Purpose: The association between rheumatoid arthritis (RA) and cardiovascular disease (CVD) is well-established, with systemic inflammation as a potential mechanism. Although atrial fibrillation (AF) is…
Abstract Number: 1638 • ACR Convergence 2025
Comparison and Assessment of the All of Us Dataset for Epidemiologic Studies of Systemic Lupus Erythematosus (SLE) Among African American Women
Katherine Singleton¹, Sarah Smith², Charmayne Dunlop-Thomas³, L. Quinnette King², Lori Ann Ueberroth⁴, Edith Williams⁵, S. Sam Lim⁶, Bethany Wolf², Diane Kamen⁷ and Paula Ramos⁶, ¹Emory University School of Medicine, Atlants, GA, ²Medical University of South Carolina, Charleston, SC, ³Emory University, Atlanta, GA, ⁴Medical University of South Carolina, Charleston, ⁵University of Rochester Medical Center, Rochester, NY, ⁶Emory University School of Medicine, Atlanta, GA, ⁷Medical University of South Carolina, Johns Island, SC
Background/Purpose: Health disparities in SLE are well established, with African American women being disproportionately impacted. Despite the known associations between sociodemographic and genetic factors with…
Abstract Number: 1342 • ACR Convergence 2025
The Impact of Age on Health-Related Quality of Life in Patients With Rheumatoid Arthritis Compared to Population Controls: A Cross-Sectional Analysis
Saskia Truijen¹, Annelies Boonen¹, Sofia Ramiro² and Marloes van Onna¹, ¹Maastricht University Medical Centre+ & Maastricht University, Maastricht, Limburg, Netherlands, ²Leiden University Medical Center, Bunde, Netherlands
Background/Purpose: As the population ages, rheumatologists will increasingly care for older persons with rheumatoid arthritis (RA). Aging comes with specific challenges of which rheumatologists are…
Abstract Number: 1026 • ACR Convergence 2025
Seasonal Variation in Public Interest in Gout Made More Crystal-Clear: A Longitudinal Infodemiology Study Using Google Trends.
Naomi Schlesinger¹ and Ioannis Androulakis², ¹Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA, Salt Lake City, UT, ²Rutgers University, Piscataway, NJ
Background/Purpose: Understanding public interest in gout, as reflected by online behavior, can offer valuable insights into its perception and management. Infodemiology, which examines the distribution…
Abstract Number: 0813 • ACR Convergence 2025
Impact of Tirzepatide on Musculoskeletal Pain and High-Risk Analgesic Use Among Non-Diabetic Patients with Overweight or Obesity: A Propensity Score-Matched, Active Comparator, New User Study
Gregory Challener¹, Kevin Sheng-Kai Ma², Natalie McCormick³, Minna Kohler⁴, Janeth Yinh³, Chio Yokose⁵, Sharan Rai⁶, Florence Porterfield⁷, Fatima Stanford⁸, Dong Wook Kim⁹, April Jorge³ and Hyon K. Choi¹⁰, ¹Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, ²Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States, Philadelphia, PA, ³Massachusetts General Hospital, Boston, MA, ⁴Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁵Massachusetts General Hospital, Waltham, MA, ⁶Massachusetts General Hospital/Harvard Medical School, Boston, MA, ⁷Division of Endocrinology, Massachusetts General Hospital, Boston, ⁸Neuroendocrine Unit, Pediatric Endocrinology, Massachusetts General Hospital, Boston, ⁹Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, Boston, ¹⁰MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA
Background/Purpose: Tirzepatide is a dual GIP/GLP-1 receptor co-agonist approved for weight loss in patients with obesity or body mass index (BMI) > 27 kg/m2 with…
Abstract Number: 0338 • ACR Convergence 2025
Fractures and Changes in Bone Mineral Density During Two Years of Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis: A Systematic Literature Review and Individual Participant Data Meta-Analysis
Andriko Palmowski¹, Tobias Haugegaard², Ingiäld Hafstörm³, Henning Bliddal⁴, Judith Oldenkott⁵, Siegfried Wassenberg⁶, Ernest Choy⁷, John Kirwan⁸, Robin Christensen⁹, Maarten Boers¹⁰ and FRANK BUTTGEREIT¹¹, ¹Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, ²The Parker Institute, Kopenhagen, Denmark, ³Karolinska Institutet, Stockholm, Sweden, ⁴The Parker Institute, Frederiksberg, Denmark, ⁵Charité, Berlin, Germany, ⁶Rheumazentrum Ratingen, Ratingen, Germany, ⁷Division of Infection and Immunity, CREATE Centre, Cardiff University, Cardiff, United Kingdom, ⁸University of Bristol, Bristol, United Kingdom, ⁹Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen, Hovedstaden, Denmark, ¹⁰Amsterdam UMC, Vrije Universiteit, Amersfoort, Netherlands, ¹¹Charité University Medicine Berlin, Berlin, Berlin, Germany
Background/Purpose: It is unclear to what extent low dose glucocorticoids (GCs) impact bone health in patients with rheumatoid arthritis (RA). RA leads to bone loss…
Abstract Number: 0146 • ACR Convergence 2025
Association between frailty and delirium and hospitalization outcomes among older adults with rheumatic diseases
Bhavik Bansal¹, Yehseo Jung², Abdulla Damluji³, Parag Goyal⁴ and Namrata Singh⁵, ¹UT Southwestern Medical Centre, Dallas, TX, ²University of Washington, Seattle, WA, ³Johns Hopkins, Baltimore, ⁴Weill Cornell, New York, ⁵University of Washington, Bellevue, WA
Background/Purpose: We investigated the association of frailty and delirium, both independently and in combination, with in-hospital mortality and non-routine discharge (i.e. when a patient is…
Abstract Number: 2567 • ACR Convergence 2025
Temporal Trends in Cardiometabolic Multimorbidity Risk in Rheumatoid Arthritis: A National, Matched Cohort Study
Tate Johnson¹, Joshua Baker², Punyasha Roul³, Grant Cannon⁴, Gary Kunkel⁵, Brian Sauer⁶, Ted Mikuls¹ and Bryant England¹, ¹University of Nebraska Medical Center, Omaha, NE, ²University of Pennsylvania, Philadelphia, PA, ³UNMC, Omaha, NE, ⁴University of Utah and Salt Lake City VA, Salt Lake City, UT, ⁵University of Utah and George E Wahlen VAMC, Salt Lake City, UT, ⁶Salt Lake City VA/University of Utah, Salt Lake City, UT
Background/Purpose: Multimorbidity, the presence of multiple chronic conditions, is over-represented in RA. A cardiometabolic multimorbidity (CMM) phenotype has emerged in the general population, but is…
Abstract Number: 2002 • ACR Convergence 2025
Methods to Address Survival Bias and Competing Risks in Estimating the Causal Risks of Gout on Dementia Risk
Joshua Baker¹, Harlan Sayles², Chung-Chou Chang³, Brian Coburn⁴, Bryant England² and Ted Mikuls², ¹University of Pennsylvania, Philadelphia, PA, ²University of Nebraska Medical Center, Omaha, NE, ³University of Pittsburgh, Pittsburgh, PA, ⁴Hospital of the University of Pennsylvania, Philadelphia, PA
Background/Purpose: Informative censoring in epidemiologic research studies (the loss of data from the risk set that is related to the exposure and/or outcome) can cause…
Abstract Number: 1891 • ACR Convergence 2025
Geographic Trends in the Burden of Gout in the United States from 1990 to 2021: A State-Level Analysis of Prevalence, Incidence, and Disability
Eva Kalra¹, Drumadala Gajbhiye², Chandana Tummala³ and Hardik Dineshbhai Desai⁴, ¹Trident Medical Center, North Charleston, SC, ²Government medical college Akola Maharashtra India ⁴⁴⁴⁰⁰¹, Akola, India, ³Internal Medicine, Vydehi Institute Of Medical Sciences and Research Centre, Whitefield-⁵⁶⁰⁰⁶⁶, Bangalore, Karnataka, India, Banglore, India, ⁴Ahmedabad, Gujarat, India, ³⁸²³⁵⁰, Ahmedabad, India
Background/Purpose: Gout, a chronic inflammatory arthritis driven by hyperuricemia, has become an increasingly significant cause of disability in the United States. Despite therapeutic advances, its…

« Previous Page
1
…
3
4
5
6
7
…
55
Next Page »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].